Show
Sort by
-
- Journal Article
- A1
- open access
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy
-
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold : an ARIA‐EAACI‐GA(2)LEN consensus
-
ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice
-
Personalized medicine for allergy treatment : allergen immunotherapy still a unique and unmatched model
-
Cabbage and fermented vegetables : from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
-
Positionspapier : Empfehlungen zur Behandlung der chronischen Rhinosinusitis während der COVID-19-Pandemie im deutschen Gesundheitssystem : Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNO-KHC) : Diese Empfehlungen basieren auf dem EAACI Positionspapier 'Treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in the COVID-19 pandemics : an EAACI position paper', Allergy, 2020 und wurden auf die Situation im deutschen Gesundheitswesen angepasst
-
- Journal Article
- A1
- open access
Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies
-
Adherence to treatment in allergic rhinitis using mobile technology : the MASK study
-
Allergic Rhinitis and its Impact on Asthma (ARIA) phase 4 (2018) : change management in allergic rhinitis and asthma multimorbidity using mobile technology
-
Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy : a randomized, double-blind, placebo-controlled trial